Top compounds associated with response to CRYAA


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib CTRPv2 pan-cancer AAC -0.021 0.6
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA FSC231 CTRPv2 pan-cancer AAC -0.043 0.6
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.03 0.6
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.018 0.6
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.03 0.6
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.023 0.6
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.02 0.6
mRNA YM-155 CTRPv2 pan-cancer AAC -0.02 0.6
Download CSV